TARPIXIS Trademark

Trademark Overview


On Wednesday, October 18, 2017, a trademark application was filed for TARPIXIS with the United States Patent and Trademark Office. The USPTO has given the TARPIXIS trademark a serial number of 87650750. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2019. This trademark is owned by H. Lundbeck A/S. The TARPIXIS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

(Based on 44(d) Priority Application) (Based on Intent to Use) Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and dise...

(Based on 44(d) Priority Application) (Based on Intent to Use) Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, ...
tarpixis

General Information


Serial Number87650750
Word MarkTARPIXIS
Filing DateWednesday, October 18, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes
Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 27, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Monday, August 19, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 19, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 21, 2018EXTENSION 1 GRANTED
Friday, December 21, 2018EXTENSION 1 FILED
Friday, December 21, 2018TEAS EXTENSION RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 13, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 30, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2018EXAMINER'S AMENDMENT ENTERED
Monday, March 26, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 26, 2018EXAMINERS AMENDMENT E-MAILED
Monday, March 26, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, March 15, 2018NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, March 15, 2018NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, March 15, 2018REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Thursday, February 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 16, 2018ASSIGNED TO LIE
Friday, February 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 29, 2018NON-FINAL ACTION E-MAILED
Monday, January 29, 2018NON-FINAL ACTION WRITTEN
Friday, January 26, 2018ASSIGNED TO EXAMINER
Friday, October 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 21, 2017NEW APPLICATION ENTERED IN TRAM